DEXA Equipment Market Size, Share, Regional Growth, 2026-2034

Market Overview

According to fortune business insights, The global DEXA equipment market size was valued at USD 583.1 million in 2025. The market is projected to grow from USD 609.7 million in 2026 to USD 917.8 million by 2034, exhibiting a CAGR of 5.2% during the forecast period. North America dominated the DEXA equipment market, holding a valuation of USD 197.5 million in 2025.

DEXA equipment is primarily used to measure bone mineral density, helping doctors diagnose osteoporosis and osteopenia, assess fracture risks, and support body composition checks. The analysis shows that market growth is attributed to the surging prevalence of bone-health problems, aging populations, longer life expectancy, and rising awareness about bone health among post-menopausal women and older men. Furthermore, a growing emphasis on preventive testing and chronic disease management is accelerating market growth. For example, in October 2024, Pharmed Limited launched the India Bone Health initiative on World Osteoporosis Day to deal with growing osteoporosis concerns across the country.

Major Players Profiled in the Market Report:

• Hologic, Inc. (U.S.)

• GE HealthCare Technologies Inc. (U.S.)

• FUJIFILM Holdings Corporation (Japan)

• Diagnostic Medical Systems Group (DMS Imaging) (France)

• Swissray International, Inc. (Taiwan)

• OsteoSys Co., Ltd. (South Korea)

• Scanflex Healthcare AB (Sweden)

• Medonica Co. LTD (South Korea)

• BeamMed Ltd. (Israel)

• Shenzhen XRAY Electric Co., Ltd. (China)

• Ningbo Xingaoyi Magnetism Co., Ltd. (China)

Segments

Higher Emphasis on Osteoporosis Detection to Boost Central DEXA Systems Segment Growth

Based on product type, the market is divided into central DEXA systems and peripheral DEXA systems. The central DEXA systems segment accounts for the largest market share owing to the rising emphasis on osteoporosis detection, a focus on long-term monitoring, and technological advancements. Hospitals and large diagnostic centers prefer them for higher patient throughput and standard reporting.

Rising Preference for Fixed Installations to Accelerate Standalone Systems Segment Growth

By portability, the market is segmented into standalone and portable. The standalone segment is leading the market as hospitals and diagnostic centers prefer stable, fixed installations that are easy to operate daily, supporting consistent workflows and repeatable results important for long-term patient monitoring.

Osteoporosis & Osteopenia Diagnosis Segment to Dominate the Market Due to High Emphasis on Disease Detection

Based on application, the market is segmented into osteoporosis & osteopenia diagnosis, body composition analysis, fracture risk assessment, pediatric bone density assessment, and others. The osteoporosis & osteopenia diagnosis segment holds the largest market share owing to the considerable prevalence of these conditions among older adults, leading to high adoption of DEXA systems for early identification and treatment tracking.

Higher Number of Scans in Hospitals to Accelerate Segment Growth

Based on end-user, the market is segmented into hospitals, diagnostic imaging centers, academic & research institutes, and others. The hospitals segment holds the highest market share as they manage large patient volumes, provide specialist orthopedic/fracture care, and run structured screening and follow-up programs.

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Source: https://www.fortunebusinessinsights.com/dexa-equipment-market-115722

Report Coverage

The report offers:

• Comprehensive study of the market size & forecast by all included market segments.

• Details on market dynamics, trends, and opportunities expected to drive the market.

• Overview of technological advancements, the regulatory environment, and product launches.

• Key strategies, partnerships, mergers & acquisitions, and investments by key regions.

• In-depth competitive landscape with information on market share and profiles of key operating players.

Drivers & Restraints

Rising Screening for Bone Health to Propel Market Growth

The soaring screening for bone health is prominently driving the global DEXA equipment market. Healthcare professionals are increasingly recommending bone density checks for older adults and high-risk populations, as early diagnosis helps prevent serious fractures. Furthermore, a shift toward preventive bone health checkups is pushing more patients toward routine testing.

However, limited access in smaller facilities due to budget limits, space constraints, and lower patient volumes may hamper market growth. Additionally, gaps in patient follow-up and repeat testing pose a critical challenge, reducing equipment utilization and the clinical value of screening programs.

Regional Insights

High Prevalence of Osteoporosis Propels Market Growth in North America

North America holds the dominant DEXA equipment market share and is projected to experience steady growth during the forecast period. The region’s growth is attributed to the higher prevalence of osteoporosis and continuous technological advancements in DEXA systems.

Asia Pacific is estimated to secure the position of the third-largest region and is witnessing considerable growth. This expansion is attributed to rising awareness about DEXA technology and strategic developments by market players in developing nations, including China, India, and Japan. Europe is also projected to record solid growth due to an increasing number of product launches and an emphasis on preventive care.

DEXA Equipment Market Future Growth:

The DEXA equipment market is experiencing steady growth, fueled by a rising emphasis on preventive care and the integration of innovative technologies. Today's healthcare providers increasingly want clearer insights into overall fracture risks beyond basic bone density. As a result, there is a strong shift toward software add-ons and advanced innovations, such as TBS (Trabecular Bone Score) technology, which produce more detailed bone health and body composition reports. This allows clinics to improve decision-making without changing scanning workflows. Furthermore, the expansion of preventive screening programs and long-term wellness checks across hospitals and imaging networks will continue to act as key growth drivers for the market.

Competitive Landscape

Growing Adoption of Collaborations and Technological Advancements to Propel Market Growth

The market features a semi-consolidated structure with prominent players like Hologic, Inc., GE HealthCare Technologies Inc., FUJIFILM Holdings Corporation, and DMS Imaging. These leading companies are accelerating growth through strategic initiatives such as technological advancements, brand enhancement, and distribution collaborations. Their proactive approach to offering better products with enhanced efficiency and accuracy continues to fuel the market’s momentum.

Key Industry Development

• July 2025: Medimaps Group S.A. signed a strategic collaboration with National Spine Health Foundation to provide analysis about TBS, for assessing bone fragility.

• May 2025: SimonMed announced the launch of its new DEXA + TBS system, a next-gen bone health screening that combines bone density and bone quality analysis.

• February 2025: HeartLung Technologies and SimonMed Imaging entered into a strategic collaboration for the development of advanced DEX equipment for the detection of osteopenia.

• August 2024: OSTEOSYS CO., LTD, received EU approval for its DXA system to help expand its presence in the European market.